Medgenome Labs Limited
ACTIVE
ISIN: INE00K708027
Issuer Details
Issuer Name
MEDGENOME LABS LIMITED
Type of Issuer
Non PSU
Sector
Diversified
Coupon Rate
0.0001%
Industry
Diversified
Issuer nature
Other
Corporate Identity Number (CIN)
U73100KA2013PLC084414
Name of the Lead Manager
-
Registrar
Maheshwari Datamatics Privat...
Name of Debenture Trustee
-
Instrument Details
Instrument name as on NSDL
0.0001% UNSECURED UNLISTED U...
Face Value (in ₹)
1000
Total Issue size( in ₹ Cr.)
6.5
Category of Instrument
-
Allotment Date
16-08-2017
Redemption Date
15-08-2027
Whether Secured or Unsecured
Unsecured
Put Option Date
-
Call Option Date
-
Seniority in Repayment
Subordinate Tier 1
Security Measures
Asset Coverage
-
Asset Percentage
-
Details of Asset Cover
N.A.
Disclaimer: Tap Bonds gathers data directly from the respective OBPP websites but does not guarantee its accuracy. We do not offer investment advice or endorse the purchase of any securities mentioned, nor do we warrant the reliability of the information collected.
Similar Bonds
MEDGENOME LABS LIMITED
ISIN: INE00K708019
Coupon Rate
0.0001%
Face Value (in ₹)
1000
MEDGENOME LABS LIMITED
ISIN: INE00K708076
Coupon Rate
0.0001%
Face Value (in ₹)
1000
MEDGENOME LABS LIMITED
ISIN: INE00K708068
Coupon Rate
0.0001%
Face Value (in ₹)
1000
MEDGENOME LABS LIMITED
ISIN: INE00K708050
Coupon Rate
0.0001%
Face Value (in ₹)
1000
About Medgenome Labs Limited bond with ISIN: INE00K708027
In the competitive landscape of fixed income securities, detailed and comprehensive information is vital for both investors and market analysts. This bond, identified by the unique ISIN INE00K708027, represents a significant financial instrument. Issued by MEDGENOME LABS LIMITED, it comes with the following description: "0.0001% UNSECURED UNLISTED UNRATED COMPULSORILY CONVERTIBLE DEBENTURES. DATE OF CONVERSION 15/08/2027". Although the bond is currently marked as active, its structure and historical context provide valuable insights into the world of debentures and non-convertible securities. The issuer, MEDGENOME LABS LIMITED, classified as Non PSU, plays an essential role in the market despite some details such as sector, industry, and issuer nature not being explicitly provided. Key identifiers like the Corporate Identification Number (CIN) U73100KA2013PLC084414 further bolster its credibility. With a coupon rate of 0.0001%, this instrument has been meticulously managed with the assistance of Maheshwari Datamatics Private Limited and under the oversight of N/A, ensuring a strong operational framework. Examining the technical specifications, the bond’s face value is 1000 with an issue size of 6.5. It was allotted on 8/16/2017 and is scheduled for redemption on 8/15/2027. Categorized under "-" and defined as Unsecured, the instrument is structured to meet specific investment objectives. Although options such as call or put are not applicable in this instance, the core attributes remain detailed and robust. A critical element in evaluating any fixed income instrument is its credit rating. No credit rating information is available for this bond. This insight helps potential investors understand that while the ratings spectrum is broad, a lower rating can indicate higher risk, prompting careful consideration before investing. The security measures add another layer of assurance. The asset cover is described as follows: N.A. – a feature that, while requiring further inquiry for complete details, underscores the issuer’s commitment to providing some level of investor protection. Furthermore, the bond is supported by several documents. There are no additional documents available for this bond. These documents serve as a reference for additional details and provide transparency to interested parties. Additionally, there are similar bonds in the market such as the bond with ISIN INE00K708019 having a coupon rate of 0.0001% and the bond with ISIN INE00K708076 having a coupon rate of 0.0001% and the bond with ISIN INE00K708068 having a coupon rate of 0.0001% and the bond with ISIN INE00K708050 having a coupon rate of 0.0001%. Such comparable instruments offer a broader perspective on market positioning and allow investors to perform benchmark analysis. This detailed description is crafted to meet rigorous content standards and to offer exhaustive insights into every facet of the bond’s structure. Investors, analysts, and researchers alike can derive substantial value from this narrative, which underscores both the instrument’s inherent characteristics and its broader market positioning. Such elaborate coverage enhances investor confidence by providing a rich, comprehensive content base. Every element from issuance details to security measures and comparative insights is meticulously presented to facilitate an informed and robust market understanding.